Crispr Therapeutics Ag (CRSP)

Net Income

-$91.15M

Quarterly · Period ending: · USD

CRSP logo

CRSP Net Income

Latest reported-$91.15M
CRSP Quarterly Net Income (-$3.24M → -$91.15M)
High-resolution chart · PNG

CRSP net income history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Net Income — Quarterly (USD)
Period endingNet Income (USD)
-91,154,000
-122,931,000
-130,613,000
-106,441,000
-208,549,000
-135,996,000
-37,311,000
-85,942,000
-126,408,000
-116,591,000
89,347,000
-112,152,000
-77,740,000
-53,065,000
-110,575,000
-174,549,000
-185,834,000
-179,217,000
-141,248,000
-127,153,000
759,225,000
-113,163,000
-107,039,000
-92,439,000
-79,656,000
-69,731,000
30,542,000
138,423,000
-53,699,000
-48,408,000
-47,590,000
-50,711,000
-38,380,000
-28,300,000
141,000
-24,707,000
-22,315,000
-21,475,000
17,098,000
-14,694,000
-17,164,000
-8,442,000
-12,286,000
-6,354,000
-3,643,000
-3,237,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.